GERN FY 2014 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-10.1% YoY

Gross Profit

-$8M-672.0% margin

Operating Income

-$36M-3149.3% margin

Net Income

-$36M-3093.7% margin

EPS (Diluted)

$-0.23

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$9M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$173M

Total Liabilities

$42M

Stockholders' Equity

$131M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$1M	-10.1%
Gross Profit	-$8M	-$8M	+1.3%
Operating Income	-$36M	-$39M	+6.8%
Net Income	-$36M	-$38M	+7.1%